BACKGROUND/OBJECTIVES: Breast cancer is a disease characterised by both oxidative reactions and inflammation. However, few studies have focused on the oxidative and inflammatory biomarkers. The aim of the present study was to evaluate the association between oxidative stress markers and adiposity and clinical staging, as well as the association between the oxidative and the antioxidant biomarkers of women with breast cancer. SUBJECTS/METHODS: A total of 135 cases of breast cancer occurring in 2011 and 2012 were assessed. After exclusions, 101 preand post-menopausal women with clinical staging I to IV were eligible to participate in the study. The anthropometric evaluation was performed by collecting data on waist circumference, body mass index and body composition. The socioeconomic and clinical profiles were determined using a standard questionnaire. For the oxidative biomarkers, thiobarbituric acid reactive substances (TBARS), oxidative DNA damage (8-hydroxy-2-deoxyguanosine (8-OHdG)), low-density lipoprotein(− ) (LDL( − )), autoantibody anti-LDL( − ) and liposoluble antioxidants (α-tocopherol, retinol and β-carotene) were analysed. The data were analysed using differences in the mean values, correlation tests and multiple linear regression. RESULTS: The antioxidant levels were higher in postmenopausal women with clinical staging I and II and negative lymph nodes. The TBARS level was associated with clinical staging. Adiposity was associated with levels of retinol and 8-OHdG, whereas LDL( − ), 8-OHdG and TBARS were correlated with liposoluble antioxidants after adjusting for the confounders. CONCLUSIONS: The adiposity and clinical staging of patients were associated with oxidative stress. The oxidative and antioxidant biomarkers showed a negative correlation in patients with breast cancer.
INTRODUCTION
Breast cancer is one the most prevalent types of cancer, with high incidence and mortality among women worldwide. 1 An estimated 235 030 new cases and 40 430 deaths from breast cancer have been reported in the USA. 2 Brazil reflects a similar pattern, and in 2014, the expected incidence of breast cancer was 56.09 new cases per 100 000 women. 3 Despite the high prevalence of the disease, the prevention, early detection and adequate treatment have helped to delay tumour recurrence and have contributed to improving the patients' quality-of-life. These benefits are directly dependent on the knowledge of the mechanism involved in the pathogenesis of breast cancer. In this condition, the redox homeostasis is disrupted and is related to an increase in oxidative stress. 4 The continuous overproduction of free radicals and reactive metabolites along with the decrease of their elimination, can allow the activation of the transcription factors that regulate several genes involved in chronic inflammation, thus contributing to several steps of carcinogenesis. 5, 6 The imbalance between oxidative species and antioxidant system induced by exogenous (diet and smoking) or endogenous (oestrogen) factors promotes oxidative stress during the initiation, promotion and progression of breast cancer. [6] [7] [8] According to the American Institute for Cancer Research (AICR), 1 observational studies have shown that a dietary pattern rich in vegetables, fruit, dairy products, fish, poultry and low fat is associated with a lower risk of breast cancer. Regarding this dietary profile, the antioxidant capacity of nutrients and other bioactive components represent a potential protective mechanism against the development of cancer. [7] [8] [9] Therefore, the evaluation of antioxidants, oxidative biomarkers and inflammatory status is crucial in clinical practice. 8-hydroxy-2deoxyguanosine (8-OHdG), malondialdehyde and antioxidant vitamins have played an important role in assessing the prognosis and the risk for the initiation and recurrence of breast cancer. [9] [10] [11] More recently, Hursting and Dunlap 12 proposed that the relationship between cancer and oxidation can change in obesity, probably because of the mechanism involved in the development of obesity, in which a chronic and low intensity inflammatory process occurs. Obese women may likely have a metabolic perturbation for oxidative reactions and for the development of breast cancer. Despite this hypothesis, few studies have investigated the impact of adiposity and clinical profile on the relationship with oxidative stress. [13] [14] [15] [16] [17] Therefore, the aim of the present study was to evaluate the association of oxidative stress markers and adiposity and clinical staging, as well as the association between the oxidant and the antioxidant biomarkers in Brazilian women with breast cancer.
MATERIALS AND METHODS Subjects
The women were recruited from the General Hospital of Fortaleza (Ceará, Brazil), after their medical appointment at the mastology clinic for preventative care of breast cancer in 2011 and 2012. The women with recent clinical and histopathological diagnosis of breast cancer, clinical staging I to IV, without previous cancer treatment or metastasis, and with a Karnofsky Performance Scale Index score of 470 (patients who are able to conduct normal activity and to work and who require no special care) 18 were selected for inclusion in the study. The exclusion criteria include metastatic cancer and use of vitamin supplements. This study was approved by the Research Ethics Committees of the General Hospital of Fortaleza (No. 050507/10) and the School of Public Health, the University of São Paulo (No. COEP 2162), and written informed consent was obtained from all of the patients. The data were collected according to good clinical practice. Before commencing the study, a training workshop was held to establish standard operating procedures among all of the researchers involved.
Socioeconomic and clinical profiles
The socioeconomic profile (age, marital status, race, education and family income) of the patients was determined by a direct interview assessment using a standard questionnaire. The patient's clinical history was obtained from the medical records and was conducted by a direct face-to-face interview. The following items were assessed: menopausal status (menopause was defined as 12 months of amenorrhea followed by reduced ovarian hormonal activity in the absence of surgical or hormonal induction), 19 nulliparity, hormone replacement therapy, breastfeeding ( ⩾3 months), smoking (cigarette, cigar or pipe smoking one or more times during the 30 days leading up to the data collection), 20 alcohol intake (415 g of ethanol/day, 21 tumour subtype, lymph nodes and tumour size.
Anthropometry and adiposity
Measurements of weight, height, waist circumference (WC) and body composition were obtained from the patients. The patient's weight was determined using a digital scale (Control, Plenna, São Paulo, Brazil), with 150 kg capacity and 100 g precision. The patient's height was measured using a stadiometer (Alturexata, Minas Gerais, Brazil) with a limit of 2.10 m and precision of 1 mm. Weight and height were utilised to calculate the body mass index (kg/m 2 ), and the patients were classified according to WHO (World Health Organization) recommendations 22 and the study by Lipschitz. 23 WC was measured at the level of the umbilicus, using an inelastic measuring tape, and the cardiometabolic risk of the patients was calculated according to the WHO classification. 22 The body composition was evaluated using bioelectrical impedance for estimating the percentage of fat mass (tetrapolar bioimpedance Biodynamic Model 450 device, São Paulo, Brazil). All of the measurements were collected in duplicate by a trained interviewer. The fat mass percentage (%FM) was classified according to the study by Lohman. 24 
Blood collection
After a 12-h fast, the blood samples were obtained by peripheral venous puncture and were collected in vacutainer tubes containing EDTA (1 mg/ml) used as an anticoagulant and antioxidant; the blood samples were stored in ice and protected from light until obtention of plasma (1500 g, 10 min, 4°C). The following protease inhibitors were added to the plasma: aprotinin (2 μg/ml), benzamidine (2 mM) and phenylmethanesulfonyl fluoride (1 mM) and the antioxidant butylated hydroxytoluene (20 mM). The plasma was aliquoted and stored at − 80°C until analysis.
Thiobarbituric acid reactive substances
Plasma (50 μl) was added to 1 ml of thiobarbituric acid (0.046 M), trichloroacetic acid (0.92 M) and hydrochloric acid (0.25 M) and subsequently incubated in a boiling water bath (100°C) for 30 min. After this period, samples were centrifuged at 4°C for 15 min at 8000 g, and supernatant (200 μl) was determined by ultraviolet absorption at 535 nm. Quantification was performed using the standard curve with 1,1,3,3 tetraethoxypropane (0.2-4.0 μmol of thiobarbituric acid reactive substances (TBARS)/L). 25 The results were expressed as micromole TBARS per milligram of protein. All of the analyses were performed in duplicate. The intra-and inter-coefficients of variation were 2.8% and 7.2%, respectively.
Oxidative DNA damage and inflammation biomarkers
The analysis of 8-OHdG was performed using a competitive ELISA kit (EIA DNA Damage, Enzo Life Sciences, Inc., Farmingdale, NY, USA) and adiponectin was analysed using sandwich enzyme immunoassay by Human Adiponectin ELISA (Enzyme-Linked Immunosorbent Assay) kit (EMD Millipore, St Charles, MO, USA).
LDL(− ) and anti-LDL( − ) autoantibody detection
Low-density lipoprotein( − ) (LDL( − )) was detected using sandwich enzyme immunoassay ELISA, according to a standardised protocol by Faulin et al. 26 The results were expressed as the mean absorbance minus the background sample and were subsequently applied to the standard curve and multiplied by the corresponding dilution. A calibration curve was conducted for each plate, using LDL( − ) extracted from the human plasma by fast protein liquid chromatography as a standard (0.6-20 μg/ml). The results were expressed as unit per litre with litre representing 1.0 g/l oxidised Apo B. The intra-and inter-coefficients of variation were 4.8% and 8.9%, respectively.
The anti-LDL( − ) autoantibody was detected using the ELISA capture antibody. The LDL( − ) isolated using fast protein liquid chromatography and ELISA method were performed according to the method previously described. 27 The results were determined by applying the average absorbance of sample background to the equation of the standard curve monoclonal antibody (0.004-0.125 mU/l). The intra-and inter-coefficients of variation were 2.8 and 6.6%, respectively.
Antioxidant analysis
The liposoluble antioxidants (α-tocopherol, retinol and β-carotene) were extracted from plasma (200 μl) by the addition of 200 μl ethanol solution (Merck, Darmstadt, Germany; high-performance liquid chromatography (HPLC)) followed by 5 s of vortex (Biomixer-MVS-1, Hamilton Beach, Washington, NC, USA). After this period, 500 μl of hexane (Merck; HPLC) was added and the final solution was mixed (2 min). The solution was centrifuged (Centrifuge Eppendorf 5415C, Eppendorf AG, Hamburg, Germany) for 5 min at 700 g at 4°C, and supernatant (250 μl) was transferred and evaporated under nitrogen. The extracted antioxidants were resuspended in 200 μl of mobile phase consisting of acetonitrile/ methanol/dichloromethane (70%:20%:10%).
The analysis of α-tocopherol, retinol and β-carotene was performed using a HPLC (Shimadzu Inc., Tokyo, Japan) that was conducted through a separation column Synergy Fusion 5μ-C8 (ref.
2) 150 ×4.6 mm column and Security Guard-HPLC Guard Cartridge System-KJO 4282 (pre-column) both from Phenomenex (Torrance, CA, USA). The effluent was monitored by SPD-10AVVP UV-vis and RF-10AXL (Shimadzu Inc.). The fluorescence detector was set at 295 nm (excitation) and 340 nm (emission). The flow of the mobile phase was 1.0 ml/min for 8 min. Retention times for α-tocopherol, retinol and β-carotene were 4.5 min, 2.5 min and 6.7 min, respectively. The curve was constructed using external standard (99%) with concentrations of α-tocopherol between 2 and 49 μmol/l, retinol between 0.2 and 6.5 μmol/l and β-carotene between 0.1 and 0.76 μmol/l. The coefficient of variation was 2.9%.
Statistical analysis
The results were evaluated using the Statistical Package for the Social Sciences (SPSS Inc., Chicago, IL, USA) version 20.0. Adherence to the normal curve was evaluated using the Kolmogorov-Smirnov test (P40.05). Pearson's correlation coefficients were calculated. The comparison of biochemical parameters between the groups was performed using Student's t-test. The multiple linear regression models were used to evaluate the associations between dependent variables (LDL(− ), anti-LDL ( − ) autoantibody, TBARS and 8-OHdG), whereas the antioxidants were considered to be independent variables. These variables were tested using a crude model (model 1) and models controlled for potential confounders: model 2-clinical staging (I and II or III and IV) and model 3-body fat percentage ( o32 or ⩾32%). Values of Po0.05 were considered to be statistically significant.
RESULTS
A total of 135 women with a mean age of 50.4 (11.3) years were initially contacted to participate in the study; however, 13 women proved to be ineligible. The women were excluded during follow-up for the following reasons: hospital transfers (n = 8), refusals (n = 5) and pretreatment of cancer or benign breast disease (n = 8). Therefore, the final sample consisted of 101 patients. The majority of the participants were premenopausal (50.5%) and 65.4% had clinical staging I and II (Table 1 ). The patients had a mean body mass index of 27.9 (4.6) kg/m 2 , mean %FM of 35.3 (4.8)% and mean WC of 96.1 (10.7) cm. The adiposity was not associated with clinical staging in this study (χ 2 = 1.720; P = 0.190).
The values of LDL(− ), autoantibody anti-LDL( − ) and 8-OHdG showed no significant differences according to the clinical profile. However, the TBARS levels were higher in the advanced clinical stage (P = 0.037). Furthermore, the mean values of α-tocopherol (P = 0.002) and retinol levels (P o0.001) were higher among the postmenopausal women. The β-carotene level showed differences as a function of clinical staging (P = 0.014), whereas the retinol levels differed with lymph node involvement (P = 0.017) ( Table 2) .
Women with a large WC had higher 8-OHdG concentrations (P = 0.020), whereas those with excess weight had a lower concentration of retinol (P = 0.019). Adiponectin concentrations were higher in patients without excess weight (P = 0.002) ( Table 3) . LDL( − ) was inversely correlated with α-tocopherol (r = −0.28, P = 0.005) and retinol (r = − 0.24, P = 0.017). The autoantibodies showed no significant correlation. 8-OHdG was inversely correlated with β-carotene (r = − 0.45, P o0.001) ( Table 4 ).
The relationship of α-tocopherol with LDL(− ) remained even after adjusting for confounders. The association of retinol with LDL ( − ) was independent of %FM and clinical staging. None of the antioxidants were associated with the anti-LDL( − ) autoantibody. The β-carotene level was associated with 8-OHdG and TBARS after adjusting for %FM and clinical staging ( Table 5 ).
DISCUSSION
Our results confirmed that antioxidants are negatively correlated with oxidative biomarkers and that oxidative stress is associated with menopausal status, clinical staging and adiposity of women with breast cancer.
The relationship between menopausal status and oxidative stress was previously described in the study by Victorino et al. 17 According to the authors, the post-menopausal women had a more favourable antioxidant profile, contributing to lower levels of oxidative damage and higher antioxidant capacity. Although the mechanism involved remains unclear, Okoh et al. 28 proposed that oestrogen stimulates the oxidation, contributing to genomic instability. This observation was confirmed by Fusell et al., 29 who demonstrated that the production of reactive oxygen species in the mammary epithelium is elevated. In addition, these women exhibited higher levels of plasma α-tocopherol and retinol.
Regarding the negative role of oxidative stress in the development of cancer, previous studies have shown that obesity in post-menopausal women can accelerate the reactive oxygen species generation. 14, 30, 31 Our results confirmed that higher values of 8-OHdG were observed in women with a large WC, whereas lower levels of retinol were correlated with an overweight status. 8-OHdG has been widely used as a biomarker of oxidative stress, and breast cancer has been considered to be a prognostic factor because a more aggressive tumour profile was associated with 8-OHdG serum levels and expression. 10 In addition to the menopausal status, clinical staging also exerts a significant impact on oxidative stress. Kumaraguruparan et al. 13 observed that the oxidant/antioxidant ratio changes as a function of normal or tumour tissue and clinical staging. Our results showed that the advanced products of lipid peroxidation (TBARS) were higher in women with clinical staging III and IV and that the β-carotene levels had reduced. Recently, Panis et al. 16 verified that at advanced clinical stages, pro-inflammatory and oxidative stimuli are present. Further supporting the oxidative basis of cancer, Pande et al. 32 concluded that women with advanced tumour stages and positive lymph nodes had lower levels of antioxidant vitamins, a finding that was corroborated by the results described in the present study. According to Pande et al., 32 the imbalances observed in the antioxidants and oxidants are related to the prognosis and clinical tumour stage. This association is directly dependent on the activation of the NF-kB p65 subunit, causing an imbalance in the homeostasis of the intracellular redox environment. 32 In the present study, β-carotene was the main antioxidant related to the oxidative biomarkers. This profile has been previously described; 7, 9, 33 however, to the best of our knowledge, this is the first time that the antioxidant has been simultaneously associated with oxidative DNA damage (8-OHdG) and lipid peroxidation (TBARS) in women with breast cancer. In addition, we have shown that LDL( − ) and α-tocopherol and retinol are inversely correlated. To date, these associations have not been reported in the literature although a relationship between LDL( − ) and α-tocopherol was previously observed in obese adolescents, 34 patients submitted to haemodialysis 35 and subjects with dyslipidaemia. 36 Delimares et al. 37 observed that the oxLDL generation was associated with an increased risk of breast cancer (odds ratio = 1.02, 95% confidence interval = 1.001-1.031), suggesting that elevated oxLDL levels, indicating the involvement of lipid peroxidation, can lead to higher oxidative stress. Recently, Khaidakov et al. 38 demonstrated pathways involved in breast cancer through the uptake of oxidised-LDL, with the stimulation of miR-21, an oncogene linked to carcinogenesis.
The LDL particles can be modified, resulting in a more electronegative LDL subfraction with oxidised characteristics 39 and proinflammatory properties. 40 Previously, we proposed that LDL( − ) is a potential early biomarker for oxidative stress; 34 this likelihood could be reinforced by their antibodies anti-LDL( − ). The present study confirms that women with breast cancer are in oxidative stress and show modified particles with different levels of oxidative damage.
The patient's clinical profile and adiposity influenced the correlations between the biomarkers, where a significant association was observed in LDL( − ) with α-tocopherol and retinol and the percentage of fat. This observation may likely be related to the fact that LDL( − ) is a biomarker of the initial oxidation process, 41 unlike TBARS and 8-OHdG. Previous studies in the literature have shown that oxidative stress in cancer is related to negative tumoural characteristics and clinical prognosis. [13] [14] [15] [16] [17] Regarding this background, our results confirm the importance of antioxidants, such as potential quencher of free radicals. To translate this scenario into clinical practice, it is likely that women with breast cancer may benefit from the increased intake of dietary antioxidants.
We also evaluated adiponectin, an anti-inflammatory biomarker and an adipocytokine related to adipose tissue and breast cancer. 42 The circulating levels of this adipokine are negatively correlated with adiposity. 12 In this study, women with higher body mass index had low plasmatic adiponectin concentrations as expected.
A limitation of this study lies in its design, which precludes the establishment of a cause-effect relationship. However, an important strength of this study is that antioxidants were evaluated using a direct method, thereby avoiding systematic and randomised bias, a common occurrence in evaluations of diet. 43, 44 These limitations are particularly relevant in studies where the number of subjects included is small and statistical analysis is not able to reduce these biases. The data of plasma antioxidants are good tools for measuring the status of these nutrients at the tissue level; however, we should be cautious in determining these results as biomarkers of dietary intake because plasma levels are not reflective of the intake, due to a series of bioavailability processes that involve such nutrients. 45, 46 Several dietary surveys, such as the food frequency questionnaire, have already been validated using such plasma nutrients, 47, 48 and good correlations with a plasmatic concentration have been observed with the consumption of fruits and vegetables. 45, 49 Finally, in women with breast cancer, the impact of antioxidants goes beyond the association with the oxidative biomarkers. Regression models broaden this view, showing that nonmodifiable (clinical staging) and modifiable (%FM) factors do not change the association between the antioxidant and the oxidative products. Therefore, we conclude that women with breast cancer are subject to oxidative stress and that this profile is directly influenced by clinical characteristics and adiposity.
